Soleno Therapeutics ( (SLNO) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Soleno Therapeutics’ stock has been buoyed by positive sentiment in the healthcare sector, with analysts maintaining a strong buy consensus. This optimism is driven by strategic company developments and favorable market conditions. Despite the stock closing at $60.12, analysts have set an average price target of $119.60, suggesting a significant potential upside.
More about Soleno Therapeutics
YTD Price Performance: 31.52%
Average Trading Volume: 1,845,086
Technical Sentiment Signal: Buy
Current Market Cap: $3.2B
For further insights into SLNO stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.